Controlled Clinical Trial on Long Term Effects of Hintonia Latiflora Extract in Mild to Moderate Type 2 Diabetes

NCT00315718 Phase 3 COMPLETED

In patients with diabetes mellitus type 2 stably adjusted to diet long-term intake of aqueous-ethanolic extract from Hintonia latiflora over more than 12 months leads to a statstically significant amelioration of parameters of glycaemic control (HbA1c, postprandial and fasting glucose) not acchievable with diet alone. As safety parameters, liver function tests and cardiovascular parameters are to be monitored. Adverse events are to be monitored.

Details

Lead sponsor	Harras Pharma Curarina GmbH
Phase	Phase 3
Status	COMPLETED
Enrolment	10
Start date	2002-06
Completion	2005-06

Conditions

• Diabetes Mellitus, Type 2

Interventions

• Extract from Hintonia latiflora bark

Primary outcomes

• HbA1c values

Countries

Slovakia